Personalized prostate cancer diagnosis and treatment—are we ready? Isabel Heidegger editorial 03 December 2018 Pages: 255 - 256
Educational no. 3: Cytogenetic analysis (CA) Martin Erdel educational 18 September 2018 Pages: 257 - 260
ASCO Congress 2018: melanoma treatment Erika Richtig short review Open access 20 November 2018 Pages: 261 - 265
ASCO 2018 NSCLC highlights—combination therapy is key Gabriele GamerithFlorian KocherAndreas Pircher short review Open access 22 October 2018 Pages: 266 - 271
The ASCO 2018 annual meeting: update on the adjuvant treatment of early breast cancer Clemens DormannKarl J. Aichberger short review 05 November 2018 Pages: 272 - 275
ASCO 2018 highlights: metastatic breast cancer Gabriel RinnerthalerSimon Peter GampenriederRichard Greil short review Open access 20 November 2018 Pages: 276 - 279
ASCO 2018: highlights in HER2-positive metastatic breast cancer Rupert BartschElisabeth Bergen short review Open access 11 October 2018 Pages: 280 - 283
ASCO 2018: highlights of urothelial cancer and prostate cancer Renate PichlerWolfgang HorningerIsabel Heidegger short review Open access 24 July 2018 Pages: 284 - 290
ASCO update 2018: upper gastrointestinal cancer Bettina SonnweberEwald Wöll short review 23 October 2018 Pages: 291 - 293
The microbiome of the prostate Christa StrasserSebastian GrafSteffen Krause short review 06 November 2018 Pages: 294 - 296
Aggressive variant and treatment-related neuroendocrine prostate cancer: two different terms for the same disease? Igor TsaurChristian Thomas short review 11 October 2018 Pages: 297 - 300
Lutetium-PSMA therapy—a new therapeutic option in metastatic castration-resistant prostate cancer? Michael LadurnerWolfgang HorningerJasmin Bektic short review 06 November 2018 Pages: 301 - 304
The impact of surgery in oligometastatic prostate cancer Jasmin BekticWolfgang Horninger short review 08 November 2018 Pages: 305 - 308
Short review of biparametric prostate MRI Fabian SteinkohlRenate PichlerDaniel Junker short review Open access 12 November 2018 Pages: 309 - 312
My burning issues in neuroendocrine tumours (NET) Barbara KiesewetterMarkus Raderer short review Open access 08 November 2018 Pages: 313 - 316
Cure in metastatic disease: how to manage and who is the right patient in colorectal cancer? Thomas GruenbergerPhillip JonasBirgit Gruenberger short review 22 October 2018 Pages: 317 - 321
Economic analysis of biomarker-based anti-EGFR therapies in metastatic colorectal cancer in the Austrian context Dora Niedersüß-BekeJudit SimonRobert M. Mader original report 11 October 2018 Pages: 322 - 329
Significance of genetic polymorphisms in hematological malignancies: implications of risk factors for prognosis and relapse Ali Amin AsnafiNiloofar FarshchiSaeid Shahrabi review 22 October 2018 Pages: 330 - 344
A rare parasitic infection: visceral leishmaniasis case after gastric cancer treatment Alkim YolcuAhmet DiricanIsmet Aydogdu case report 01 October 2018 Pages: 345 - 347
Cryptococcal meningitis in an immunocompetent patient with primary myelofibrosis on long-term ruxolitinib: report of a rare case and review of literature Amrita ChakrabartiNitin Sood case report 18 September 2018 Pages: 348 - 350